---
figid: PMC4190552__cancers-06-01500-g001
figlink: /pmc/articles/PMC4190552/figure/cancers-06-01500-f001/
number: F1
caption: The roles of leukotrienes and acetylation in the expression of pro-inflammatory
  mediators through the NF-κB pathway. The activated cPLA2α produces arachidonic acid,
  which is further converted to LTA4 by the 5-LOX. LTA4 is then converted to LTB4
  and cys-LTs and their binding to the leukotriene receptors activate the NF-κB pathway
  in leukocytes during inflammation. cPLA2α—cytosolic phospholipase A2-α; 5-LOX—5-lipoxygenase;
  LTA4—leukotriene A4; LTB4—leukotriene B4; Cys-LTs—cysteinyl leukotrienes; LTBR1/2—leukotriene
  B receptors 1 or 2; CysLTR1/2—cysteinyl leukotriene receptors 1 or 2; PI3K—phosphoinositide
  3-kinase; PKC—protein kinase C; NEMO—NF-κB essential modulator; IκBα—inhibitor NF-κB;
  IKK—IκB kinase; NIK—NF-κB activation of inducing kinase; HAT—histone acetyltransferase.
  TNFα—tumor necrosis factor α; MIP—2-macrophage inflammatory protein-2; COX-2—cycloxygenas-2;
  iNOS—inducible nitric oxide synthase.
pmcid: PMC4190552
papertitle: Inflammation, Cancer and Oxidative Lipoxygenase Activity are Intimately
  Linked.
reftext: Rosalina Wisastra, et al. Cancers (Basel). 2014 Sep;6(3):1500-1521.
pmc_ranked_result_index: '135747'
pathway_score: 0.8890588
filename: cancers-06-01500-g001.jpg
figtitle: Roles of leukotrienes and acetylation in the expression of pro-inflammatory
  mediators through the NFKB pathway
year: '2014'
organisms: Homo sapiens
ndex: 71de70c1-df12-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4190552__cancers-06-01500-g001.html
  '@type': Dataset
  description: The roles of leukotrienes and acetylation in the expression of pro-inflammatory
    mediators through the NF-κB pathway. The activated cPLA2α produces arachidonic
    acid, which is further converted to LTA4 by the 5-LOX. LTA4 is then converted
    to LTB4 and cys-LTs and their binding to the leukotriene receptors activate the
    NF-κB pathway in leukocytes during inflammation. cPLA2α—cytosolic phospholipase
    A2-α; 5-LOX—5-lipoxygenase; LTA4—leukotriene A4; LTB4—leukotriene B4; Cys-LTs—cysteinyl
    leukotrienes; LTBR1/2—leukotriene B receptors 1 or 2; CysLTR1/2—cysteinyl leukotriene
    receptors 1 or 2; PI3K—phosphoinositide 3-kinase; PKC—protein kinase C; NEMO—NF-κB
    essential modulator; IκBα—inhibitor NF-κB; IKK—IκB kinase; NIK—NF-κB activation
    of inducing kinase; HAT—histone acetyltransferase. TNFα—tumor necrosis factor
    α; MIP—2-macrophage inflammatory protein-2; COX-2—cycloxygenas-2; iNOS—inducible
    nitric oxide synthase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ADCY8
  - PRKCB
  - PRKCE
  - PRKCG
  - PRKCH
  - ADCY6
  - ADCY7
  - LTB
  - PRKCA
  - PRKCD
  - PRKCI
  - PRKD3
  - ALOX5
  - ADCY10
  - ADCY9
  - ADCY3
  - ADCY5
  - LTA
  - IKBKG
  - TNF
  - PRKCZ
  - ADCY4
  - CHUK
  - PRKCQ
  - ADCY1
  - RELB
  - CYSLTR2
  - ADCY2
  - CYSLTR1
  - Arachidonic acid
  - Cys
genes:
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: LTB,
  symbol: LTB
  source: hgnc_symbol
  hgnc_symbol: LTB
  entrez: '4050'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: 5-LOX
  symbol: 5-LOX
  source: hgnc_alias_symbol
  hgnc_symbol: ALOX5
  entrez: '240'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: LTA,
  symbol: LTA
  source: hgnc_symbol
  hgnc_symbol: LTA
  entrez: '4049'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: TNFA
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: IKKA
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: RelB
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: CYSLTR1/2
  symbol: CYSLTR2
  source: hgnc_symbol
  hgnc_symbol: CYSLTR2
  entrez: '57105'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: CYSLTR1/2
  symbol: CYSLTR1
  source: hgnc_symbol
  hgnc_symbol: CYSLTR1
  entrez: '10800'
chemicals:
- word: Arachidonic acid
  source: MESH
  identifier: D001095
- word: Cys
  source: MESH
  identifier: D003545
diseases: []
figid_alias: PMC4190552__F1
redirect_from: /figures/PMC4190552__F1
figtype: Figure
---
